Cargando…
Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells
Cystic Fibrosis (CF) patients are prone to contracting bacterial lung infections with opportunistic pathogens, especially Pseudomonas aeruginosa. Prolonged P. aeruginosa infections have been linked to chronic inflammation in the CF lung, whose hallmarks are increased levels of cytokines (i.e., TNF-α...
Autores principales: | Laselva, Onofrio, Criscione, Maria Laura, Allegretta, Caterina, Di Gioia, Sante, Liso, Arcangelo, Conese, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322660/ https://www.ncbi.nlm.nih.gov/pubmed/35903151 http://dx.doi.org/10.3389/fmolb.2022.905468 |
Ejemplares similares
-
Anti-Inflammatory and Anti-Oxidant Effect of Dimethyl Fumarate in Cystic Fibrosis Bronchial Epithelial Cells
por: Laselva, Onofrio, et al.
Publicado: (2021) -
Editorial: Mechanisms of Novel Drugs and Gene Modifiers in the Treatment of Cystic Fibrosis
por: Veit, Guido, et al.
Publicado: (2022) -
IGFBP-6 Network in Chronic Inflammatory Airway Diseases and Lung Tumor Progression
por: Venuto, Santina, et al.
Publicado: (2023) -
Elexacaftor/Tezacaftor/Ivacaftor Accelerates Wound Repair in Cystic Fibrosis Airway Epithelium
por: Laselva, Onofrio, et al.
Publicado: (2022) -
From fever to immunity: A new role for IGFBP‐6?
por: Liso, Arcangelo, et al.
Publicado: (2018)